Drugs / Vamifeport
Vamifeport
Trials 7
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 13 trials | ||||||
| Phase 1 | NCT06996184 | May → Jul 2025 | — | CSL Behring | Completed | No outcome recorded |
| Phase 1 | NCT06726863 | Nov 2024 → Jan 2025 | — | CSL Behring | Completed | No outcome recorded |
| Phase 1 | NCT05077436 | Oct → Dec 2021 | — | Vifor (International) Inc. | Completed | No outcome recorded |
| Phase 24 trials | ||||||
| Phase 2 | NCT07332091 | Jan 2026 → Mar 2028 expected | hemochromatosis type 1 | CSL Behring | Recruiting | No outcome recorded |
| Phase 2 | NCT04817670 | Nov 2021 → Mar 2024 | sickle cell disease | Vifor (International) Inc. | Completed | No outcome recorded |
| Phase 2 | NCT04938635 | Sep 2021 → Jul 2023 | beta thalassemia | Vifor (International) Inc. | Withdrawn | No outcome recorded Stop: Business |
| Phase 2 | NCT04364269 | Jun 2020 → Oct 2021 | beta-thalassemia intermedia | Vifor (International) Inc. | Completed | No outcome recorded |
Press releases naming this drug 1 release
| Date | Issuer | Release |
|---|---|---|
| 2021-12-10 | CSL Behring | First patient enrolled in phase-IIa study of vamifeport in patients with sickle cell disease csl.com ↗ |
Evidence & citations 10 cited values
Every value below carries the sentence it was read from. 8 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Vamifeport | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05077436 ↗ |
| Known as | VAMIFEPORT HYDROCHLORIDE | ChEMBL registry synonym — accepted as the source's own label CHEMBL4596566 ↗ |
| Known as | Vamifeport trihydrochloride | ChEMBL registry synonym — accepted as the source's own label CHEMBL4596566 ↗ |
| Known as | VIT- 2763-PM1 | ChEMBL registry synonym — accepted as the source's own label CHEMBL4596566 ↗ |
| Known as | VIT-2763 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04938635 ↗ |
| Known as | VIT-2763 3HCl | ChEMBL registry synonym — accepted as the source's own label CHEMBL4596566 ↗ |
| Known as | VIT-2763 trihydrochloride | ChEMBL registry synonym — accepted as the source's own label CHEMBL4596566 ↗ |
| Known as | VIT-2763-PM1 TRIHYDROCHLORIDE | ChEMBL registry synonym — accepted as the source's own label CHEMBL4596566 ↗ |
| Modality | Small molecule | — CHEMBL4596566 ↗ |
| Route | Oral | “Capsules are to be taken orally.” NCT04817670 ↗ |